Am J Obstet Gynecol. 2003 Nov;189(5):1398-400. doi: 10.1067/s0002-9378(03)00777-4.
PMID:14634576
[Analysis of vaginal microecology in 23 181 cases of the gynecological female outpatients].
Zong XN, Feng YZ, Bai HH, Wang HSQ, Shang X, Fan LY, Li T, Zhang Z, Du MY, Liu ZH.
Zhonghua Fu Chan Ke Za Zhi. 2023 Mar 25;58(3):191-197. doi: 10.3760/cma.j.cn112141-20221212-00754.
PMID:36935196
Multipurpose prevention technologies: the future of HIV and STI protection.
Fernández-Romero JA, Deal C, Herold BC, Schiller J, Patton D, Zydowsky T, Romano J, Petro CD, Narasimhan M.
Trends Microbiol. 2015 Jul;23(7):429-436. doi: 10.1016/j.tim.2015.02.006. Epub 2015 Mar 7.
PMID:25759332
Sexually Transmitted Infections in Pregnancy: A Narrative Review of the Global Research Gaps, Challenges, and Opportunities.
Grant JS, Chico RM, Lee AC, Low N, Medina-Marino A, Molina RL, Morroni C, Ramogola-Masire D, Stafylis C, Tang W, Vallely AJ, Wynn A, Yeganeh N, Klausner JD.
Sex Transm Dis. 2020 Dec;47(12):779-789. doi: 10.1097/OLQ.0000000000001258.
PMID:32773611
Development and validation of a predictive model for the risk of developing trichomonas vaginitis in women.
Li Q, Li Y, Bai Y, Zhang H, Zhao W.
Sci Rep. 2022 Nov 23;12(1):20182. doi: 10.1038/s41598-022-24396-y.
PMID:36424393
Nitazoxanide and tizoxanide demonstrate high levels of in vitro activity against metronidazole-susceptible and metronidazole-resistant Trichomonas vaginalis clinical isolates.
Microbiol Spectr. 2025 Jul;13(7):e0271724. doi: 10.1128/spectrum.02717-24. Epub 2025 May 22.
PMID:40401974
[Therapy of combined vaginal infections with Trichomonas vaginalis and Blastomycetes. A controlled double-blind comparison of Metronidazole and Clotrimazole].
Schnell JD, Rüther C.
Geburtshilfe Frauenheilkd. 1974 Jul;34(7):551-7.
PMID:4849985
Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.